August 11, 2020
Via: BioSpaceAmerican Gene Technologies (AGT) announced today approval by the Food and Drug Administration (FDA) to begin Phase 1, the first human clinical trial for AGT’s lead HIV program. AGT will conduct its Phase 1 study at clinical sites in the […]
July 11, 2024
July 11, 2024
July 19, 2024